vs
Generac（GNRC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Generac的季度营收约是Royalty Pharma plc的1.7倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 6.9%，领先27.5%），Generac同比增速更快（12.4% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 3.0%）
Generac Holdings Inc.（简称Generac）是美国财富1000强企业，主营面向住宅、小型商业及工业领域的备用发电产品，功率覆盖800瓦至9兆瓦，通过独立经销商、零售商及批发商渠道发售，总部位于威斯康星州沃基肖，在该州多地设有生产基地。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GNRC vs RPRX — 直观对比
营收规模更大
GNRC
是对方的1.7倍
$622.0M
营收增速更快
GNRC
高出7.7%
4.8%
净利率更高
RPRX
高出27.5%
6.9%
两年增速更快
RPRX
近两年复合增速
3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $73.1M | $214.2M |
| 毛利率 | 38.7% | — |
| 营业利润率 | 11.1% | 62.4% |
| 净利率 | 6.9% | 34.4% |
| 营收同比 | 12.4% | 4.8% |
| 净利润同比 | 65.1% | 2.9% |
| 每股收益（稀释后） | $1.24 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GNRCRPRX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $942.1M | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $998.2M | $537.3M |
净利润GNRCRPRX
| Q1 26 | $73.1M | — | ||
| Q4 25 | $-24.5M | $214.2M | ||
| Q3 25 | $66.2M | $288.2M | ||
| Q2 25 | $74.0M | $30.2M | ||
| Q1 25 | $43.8M | $238.3M | ||
| Q4 24 | $117.2M | $208.2M | ||
| Q3 24 | $113.7M | $544.0M | ||
| Q2 24 | $59.1M | $102.0M |
毛利率GNRCRPRX
| Q1 26 | 38.7% | — | ||
| Q4 25 | 36.3% | — | ||
| Q3 25 | 38.3% | — | ||
| Q2 25 | 39.3% | — | ||
| Q1 25 | 39.5% | — | ||
| Q4 24 | 40.6% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 37.6% | — |
营业利润率GNRCRPRX
| Q1 26 | 11.1% | — | ||
| Q4 25 | -0.9% | 62.4% | ||
| Q3 25 | 9.3% | 70.1% | ||
| Q2 25 | 10.5% | 36.3% | ||
| Q1 25 | 8.9% | 94.0% | ||
| Q4 24 | 16.0% | 60.9% | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 10.3% | 50.2% |
净利率GNRCRPRX
| Q1 26 | 6.9% | — | ||
| Q4 25 | -2.2% | 34.4% | ||
| Q3 25 | 5.9% | 47.3% | ||
| Q2 25 | 7.0% | 5.2% | ||
| Q1 25 | 4.7% | 41.9% | ||
| Q4 24 | 9.5% | 35.1% | ||
| Q3 24 | 9.7% | 96.3% | ||
| Q2 24 | 5.9% | 19.0% |
每股收益（稀释后）GNRCRPRX
| Q1 26 | $1.24 | — | ||
| Q4 25 | $-0.41 | $0.49 | ||
| Q3 25 | $1.12 | $0.67 | ||
| Q2 25 | $1.25 | $0.07 | ||
| Q1 25 | $0.73 | $0.55 | ||
| Q4 24 | $2.14 | $0.46 | ||
| Q3 24 | $1.89 | $1.21 | ||
| Q2 24 | $0.97 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $265.5M | $618.7M |
| 总债务越低越好 | $44.0M | $9.0B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $5.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GNRCRPRX
| Q1 26 | $265.5M | — | ||
| Q4 25 | $341.4M | $618.7M | ||
| Q3 25 | $300.0M | $938.9M | ||
| Q2 25 | $223.5M | $631.9M | ||
| Q1 25 | $187.5M | $1.1B | ||
| Q4 24 | $281.3M | $929.0M | ||
| Q3 24 | $214.2M | $950.1M | ||
| Q2 24 | $218.3M | $1.8B |
总债务GNRCRPRX
| Q1 26 | $44.0M | — | ||
| Q4 25 | $1.3B | $9.0B | ||
| Q3 25 | $1.4B | $8.9B | ||
| Q2 25 | $1.3B | $8.0B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.6B | ||
| Q3 24 | $1.4B | $7.6B | ||
| Q2 24 | $1.4B | $7.6B |
股东权益GNRCRPRX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.6B | $9.7B | ||
| Q3 25 | $2.6B | $9.6B | ||
| Q2 25 | $2.6B | $9.5B | ||
| Q1 25 | $2.5B | $9.8B | ||
| Q4 24 | $2.5B | $10.3B | ||
| Q3 24 | $2.4B | $10.3B | ||
| Q2 24 | $2.4B | $9.8B |
总资产GNRCRPRX
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.6B | $19.6B | ||
| Q3 25 | $5.6B | $19.3B | ||
| Q2 25 | $5.4B | $18.3B | ||
| Q1 25 | $5.1B | $17.6B | ||
| Q4 24 | $5.1B | $18.2B | ||
| Q3 24 | $5.2B | $18.0B | ||
| Q2 24 | $5.1B | $17.7B |
负债/权益比GNRCRPRX
| Q1 26 | 0.02× | — | ||
| Q4 25 | 0.48× | 0.92× | ||
| Q3 25 | 0.51× | 0.93× | ||
| Q2 25 | 0.50× | 0.84× | ||
| Q1 25 | 0.48× | 0.78× | ||
| Q4 24 | 0.49× | 0.74× | ||
| Q3 24 | 0.56× | 0.74× | ||
| Q2 24 | 0.61× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $119.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $89.9M | — |
| 自由现金流率自由现金流/营收 | 8.5% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.63× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $330.8M | — |
8季度趋势，按日历期对齐
经营现金流GNRCRPRX
| Q1 26 | $119.3M | — | ||
| Q4 25 | $189.3M | $827.1M | ||
| Q3 25 | $118.4M | $702.6M | ||
| Q2 25 | $72.2M | $364.0M | ||
| Q1 25 | $58.2M | $596.1M | ||
| Q4 24 | $339.5M | $742.5M | ||
| Q3 24 | $212.3M | $703.6M | ||
| Q2 24 | $77.7M | $658.2M |
自由现金流GNRCRPRX
| Q1 26 | $89.9M | — | ||
| Q4 25 | $129.9M | — | ||
| Q3 25 | $96.5M | — | ||
| Q2 25 | $14.5M | — | ||
| Q1 25 | $27.2M | — | ||
| Q4 24 | $286.1M | — | ||
| Q3 24 | $183.7M | — | ||
| Q2 24 | $49.7M | — |
自由现金流率GNRCRPRX
| Q1 26 | 8.5% | — | ||
| Q4 25 | 11.9% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 5.0% | — |
资本支出强度GNRCRPRX
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 2.8% | — |
现金转化率GNRCRPRX
| Q1 26 | 1.63× | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.79× | 2.44× | ||
| Q2 25 | 0.98× | 12.06× | ||
| Q1 25 | 1.33× | 2.50× | ||
| Q4 24 | 2.90× | 3.57× | ||
| Q3 24 | 1.87× | 1.29× | ||
| Q2 24 | 1.31× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GNRC
| Residential | $549.3M | 52% |
| Commercial & Industrial | $510.0M | 48% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
